Published by Coherent Market Insights
Posted on October 8, 2021
5 min readLast updated: January 30, 2026
The Psoriatic Arthritis Treatment market is set to grow significantly by 2028, driven by new drug approvals and clinical trials.
The global Psoriatic Arthritis Treatment market is expected to reach US$ 17,765.0 Mn by 2028 from US$ 10,100.9 Mn in 2020, at a CAGR of 8.4%. The base year considered for the study is 2020 and the forecast period 2021-2028.
Psoriatic arthritis is one of the types of inflammatory arthritis that occurs in some people suffering from psoriasis, a skin condition wherein red, scaly patches appear on the skin. Usually, psoriasis is followed by psoriatic arthritis, however, pain in joints may start even before any patches are visible on the skin of the patient. Some of the symptoms associated with psoriatic arthritis include pain, swelling, and stiffness in joints. Painful, swelling of fingers and toes can be observed in patients suffering from psoriatic arthritis. Some people suffer from spondylitis caused due to psoriatic arthritis. In spondylitis, inflammation of joints between vertebrae and spine occurs along with inflammation in joints between spine and pelvis. Some of the factors that increase the risk of psoriatic arthritis include age, genetics, and having psoriasis. Psoriatic arthritis is incurable, thus it is important to manage its symptoms using available therapeutic drugs related to psoriatic arthritis. This is expected to drive the growth of psoriatic arthritis market.
Request Sample Psoriatic Arthritis Treatment market Report @
https://www.coherentmarketinsights.com/insight/request-sample/4624
Key players operating in the market are focusing on submitting application for approval of drugs for the treatment of psoriatic arthritis, which is expected to drive the growth of the global psoriatic arthritis treatment market over the forecast period.
For instance, in April 2021, AbbVie Inc., a U.S.-based biopharmaceutical company, announced that the company had submitted Biologics License Application to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) in order to seek approval for its drug SKYRIZI. SKYRIZI is an interleukin inhibitor which can be used for the treatment of active psoriatic arthritis in adults.
Moreover, according to ClinicalTrials.gov, a Phase 3 clinical trial study was initiated by AbbVie Inc. in March 2019 to determine the potential use of its drug Risankizumab (SKYRIZI) in patients suffering from active psoriatic arthritis who are intolerant to biologic therapy or non-biologic disease-modifying anti-rheumatic drugs (DMARDs). The Phase 3 results of SKYRIZI show that the drug is safe and effective to be used for the treatment of active psoriatic arthritis in adults.
Ask for PDF sample Psoriatic Arthritis Treatment market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4624
The objectives of this study are as follows:
To define, describe, and forecast the global Psoriatic Arthritis Treatment market by product & service, technique, design, application, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players
To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze competitive developments in the Psoriatic Arthritis Treatment market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4624
Available Customizations
With the given market data, Coherent Market Insights offers customizations as per the company‘s specific needs.
The following customization options are available for this report.
This report segments the Psoriatic Arthritis Treatment market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2020, the test kits segment accounted for the largest share of the total market. The growing demand for Psoriatic Arthritis Treatment in research as well as diagnostics to understand the genetic variability of chronic disorders is propelling the growth of this Psoriatic Arthritis Treatment market segment.
Based on design, the Psoriatic Arthritis Treatment market is segmented into predesigned and customized panels. The customized Psoriatic Arthritis Treatment segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
The Psoriatic Arthritis Treatment market is fragmented with the presence of several small and big players. Prominent players in this market include AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Amgen Inc., Sanofi S.A., Johnson & Johnson Services, Inc., Novartis International AG, AstraZeneca, Bausch Health Companies Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, , Eli Lilly and Company, Pfizer, Inc., UCB S.A., Sun Pharma Global FZE, AltruBio, Merck & Co Inc., and Celgene Corporation
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Psoriatic Arthritis Treatment Market to See Incredible Growth 2021-2028 | AbbVie, Otsuka Pharmaceutical Co., Ltd., Amgen appeared first on Gatorledger.
The article discusses the growth and forecast of the Psoriatic Arthritis Treatment market from 2021 to 2028.
What are the key drivers of market growth? New drug approvals and clinical trials are major drivers.
Who are the key players in the market? AbbVie, Otsuka Pharmaceutical, and Amgen are notable companies.
Explore more articles in the Research Reports category
